Maxidex For Suspension
Product Images NDC 82667-600

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Maxidex (NDC 82667-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harrow Eye, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Max08 0000 01)

Chemical structure of dexamethasone as shown in the image, depicting its molecular arrangement with hydroxyl, carbonyl, fluorine, and methyl groups.*

FDA Label Image

Figure (Max08 0000 02)

MAXIDEX 0.1% (dexamethasone ophthalmic suspension) for suspension is shown in a 5 mL ophthalmic dropper bottle carton. The label states it is sterile and for topical ophthalmic use. The carton also includes storage instructions, active and inactive ingredients, and the labeler Harrow Eye, LLC, Nashville, TN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.